Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Earlier tirzepatide use outperforms other GLP-1s in type 2 diabetes A company-funded study found that recently diagnosed type 2 diabetes patients whose disease was not adequately controlled with metformin fared significantly better when tirzepatide was added to their regimen compared to other drugs in the GLP-1 class
It has previously been linked to improved outcomes in patients with sleep apnea and heart failure with preserved ejection fraction
half-life ~155 hours enabling once-weekly dosing
Contact us or schedule an appointment and start your journey toward better health and sustainable weight management
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
